Abstract
Adamantinoma is a rare primary bone neoplasm with epithelial differentiation that is frequently associated with a concomitant fibrous component. Clinical, cytogenetic and histomorphologic overlap has previously been described with osteofibrous dysplasia, thereby suggesting a relationship between these two lesions. We performed a retrospective review of our archives to characterize the clinical and pathologic aspects of adamantinoma and osteofibrous dysplasia diagnosed at our institution, and to compare the expression patterns of p63 and keratin. Nine cases of adamantinoma (six classical, three osteofibrous dysplasia-like) and 11 cases of osteofibrous dysplasia were identified. The epithelial component in adamantinoma was found to stain for p63. Rare cells expressing p63 were also identified in eight cases of osteofibrous dysplasia. Expression of p63 was not identified in any of the five cases of fibrous dysplasia controls. The presence of staining for p63, albeit rare, in osteofibrous dysplasia supports the notion of a possible relationship between osteofibrous dysplasia and adamantinoma. Furthermore, our results suggest that, in some situations, p63 may be useful in helping differentiate metastatic carcinoma from adamantinoma.
Similar content being viewed by others
References
Hogendoorn PCW, Hashimoto H (2002) Adamantinoma. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology & Genetics: Tumours of Soft Tissue and Bone. IARC Press, Lyon, pp 332–334
Weiss SW, Dorfman HD (1977) Adamantinoma of long bone. An analysis of nine new cases with emphasis on metastasizing lesions and fibrous dysplasia-like changes. Hum Pathol 8:141–153
Unni KK, Dahlin DC, Beabout JW, Ivins JC (1974) Adamantinomas of long bones. Cancer 34:1796–1805
Czerniak B, Rojas-Corona RR, Dorfman HD (1989) Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer 64:2319–2334
Keeney GL, Unni KK, Beabout JW, Pritchard DJ (1989) Adamantinoma of long bones. A clinicopathologic study of 85 cases. Cancer 64:730–737
Mills SE, Rosai J (1985) Adamantinoma of the pretibial soft tissue. Clinicopathologic features, differential diagnosis, and possible relationship to intraosseous disease. Am J Clin Pathol 83:108–114
Bambirra EA, Nogueira AM, Miranda D (1983) Adamantinoma of the soft tissue of the leg. Arch Pathol Lab Med 107:500–501
Campanacci M, Laus M (1981) Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg Am 63:367–375
Benassi MS, Campanacci L, Gamberi G, Ferrari C, Picci P, Sangiorgi L, Campanacci M (1994) Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis. Histopathology 25:71–76
Cohen DM, Dahlin DC, Pugh DG (1962) Fibrous dysplasia associated with adamantinoma of the long bones. Cancer 15:515–521
Hazelbag HM, Laforga JB, Roels HJ, Hogendoorn PC (2003) Dedifferentiated adamantinoma with revertant mesenchymal phenotype. Am J Surg Pathol 27:1530–1537
Izquierdo FM, Ramos LR, Sanchez-Herraez S, Hernandez T, de Alava E, Hazelbag HM (2010) Dedifferentiated classic adamantinoma of the tibia: a report of a case with eventual complete revertant mesenchymal phenotype. Am J Surg Pathol 34:1388–1392
Rosai J (1969) Adamantinoma of the tibia. Electron microscopic evidence of its epithelial origin. Am J Clin Pathol 51:786–792
Knapp RH, Wick MR, Scheithauer BW, Unni KK (1982) Adamantinoma of bone. An electron microscopic and immunohistochemical study. Virchows Arch A Pathol Anat Histopathol 398:75–86
Mori H, Yamamoto S, Hiramatsu K, Miura T, Moon NF (1984) Adamantinoma of the tibia. Ultrastructural and immunohistochemic study with reference to histogenesis Clin Orthop Relat Res 190:299–310
Ishida T, Iijima T, Kikuchi F, Kitagawa T, Tanida T, Imamura T, Machinami R (1992) A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 21:493–502
Bertoni F, Campanacci M (1976) Ewing’s sarcoma of the soft tissues? Case report. Ital J Orthop Traumatol 2:413–416
Hazelbag HM, Taminiau AH, Fleuren GJ, Hogendoorn PC (1994) Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am 76:1482–1499
Kumamoto H, Ohki K, Ooya K (2005) Expression of p63 and p73 in ameloblastomas. J Oral Pathol Med 34:220–226
Campanacci M (1976) Osteofibrous dysplasia of long bones a new clinical entity. Ital J Orthop Traumatol 2:221–237
Campanacci M, Giunti A, Bertoni F, Laus M, Gitelis S (1981) Adamantinoma of the long bones. The experience at the Istituto Ortopedico Rizzoli. Am J Surg Pathol 5:533–542
Bridge JA, Dembinski A, DeBoer J, Travis J, Neff JR (1994) Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer 73:1746–1752
Hazelbag HM, Wessels JW, Mollevangers P, van den Berg E, Molenaar WM, Hogendoorn PC (1997) Cytogenetic analysis of adamantinoma of long bones: further indications for a common histogenesis with osteofibrous dysplasia. Cancer Genet Cytogenet 97:5–11
Rosai J, Pinkus GS (1982) Immunohistochemical demonstration of epithelial differentiation in adamantinoma of the tibia. Am J Surg Pathol 6:427–434
Hazelbag HM, Fleuren GJ, vd Broek LJ, Taminiau AH, Hogendoorn PC (1993) Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis. Am J Surg Pathol 17:1225–1233
Fischer B (1913) Über ein primäres adamantinoma der tibia. Frankf Z Pathol 12:422–441
Ryrie BJ (1932) Adamantinoma of the tibia: aetiology and pathogenesis. Br Med J 2:1000–1003
Hazelbag, HM (1996) On the histogenesis of adamantinoma of long bones. Ph.D. Thesis, University of Leiden, Leiden
Hazelbag HM, Van den Broek LJ, Fleuren GJ, Taminiau AH, Hogendoorn PC (1997) Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation. Hum Pathol 28:183–188
Bovee JV, van den Broek LJ, de Boer WI, Hogendoorn PC (1998) Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis. J Pathol 184:24–30
Baker PL, Dockerty MB, Coventry MB (1954) Adamantinoma (so-called) of the long bones; review of the literature and report of three new cases. J Bone Joint Surg Am 36-A:704–720
Ueda Y, Blasius S, Edel G, Wuisman P, Bocker W, Roessner A (1992) Osteofibrous dysplasia of long bones—a reactive process to adamantinomatous tissue. J Cancer Res Clin Oncol 118:152–156
Gleason BC, Liegl-Atzwanger B, Kozakewich HP, Connolly S, Gebhardt MC, Fletcher JA, Perez-Atayde AR (2008) Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal. Am J Surg Pathol 32:363–376
Dockerty MB, Meyerding HW (1942) Adamantinoma of the tibia: report of two new cases. J Am Med Assoc 119:932–937
Springfield DS, Rosenberg AE, Mankin HJ, Mindell ER (1994) Relationship between osteofibrous dysplasia and adamantinoma. Clin Orthop Relat Res 309:234–244
Kashima, TG Dongre, A Flanagan, AM Hogendoorn, PC Taylor, R Athanasou NA (2011) Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia. Virchows Arch. doi:10.1007/s00428-011-1081-2
Sweet DE, Vinh TN, Devaney K (1992) Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma. A clinicopathologic study of 30 cases. Am J Surg Pathol 16:282–290
Yang A, McKeon F (2000) P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:199–207
Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G (2010) p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2:a004887
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714–718
van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG (2001) p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype–phenotype correlation. Am J Hum Genet 69:481–492
Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708–713
Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 98:3156–3161
Brunner HG, Hamel BC, Bokhoven Hv H (2002) P63 gene mutations and human developmental syndromes. Am J Med Genet 112:284–290
Reis-Filho JS, Schmitt FC (2002) Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 9:280–289
Blanpain C, Fuchs E (2007) p63: revving up epithelial stem-cell potential. Nat Cell Biol 9:731–733
Senoo M, Pinto F, Crum CP, McKeon F (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523–536
Chun-mao H, Su-yi W, Ping-ping L, Hang-hui C (2007) Human bone marrow-derived mesenchymal stem cells differentiate into epidermal-like cells in vitro. Differentiation 75:292–298
Acknowledgements
The authors are grateful for the technical assistance of Ms. Patricia Wegrynowski and Mr. Anthony Wing. In addition, Mr. Anthony Griffin provided invaluable assistance in reviewing the clinical records.
This research was presented at the 2010 Meeting of the US and Canadian Academy of Pathology (Washington, DC, USA).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dickson, B.C., Gortzak, Y., Bell, R.S. et al. p63 expression in adamantinoma. Virchows Arch 459, 109–113 (2011). https://doi.org/10.1007/s00428-011-1101-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-011-1101-2